Literature DB >> 16821069

[Comorbidities of COPD].

H Watz1, H Magnussen.   

Abstract

Chronic obstructive pulmonary disease (COPD) is often associated with comorbidities. Cardiovascular diseases, weight loss, loss of fat free mass combined with muscle dysfunction, osteoporosis and depression are the main comorbidities in COPD. Cardiovascular comorbidities, weight loss and loss of fat free mass are predictors of mortality of patients with COPD. Thus, the extrapulmonary manifestations are meaningful parameters of clinical assessment. Systemic inflammation is probably the key to the extrapulmonary signs of COPD.

Entities:  

Mesh:

Year:  2006        PMID: 16821069     DOI: 10.1007/s00108-006-1675-y

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  54 in total

Review 1.  Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-04       Impact factor: 21.405

Review 2.  Markers of hemostasis and systemic inflammation in heart disease and atherosclerosis in smokers.

Authors:  Peter K MacCallum
Journal:  Proc Am Thorac Soc       Date:  2005

Review 3.  Local and systemic inflammation in chronic obstructive pulmonary disease.

Authors:  Emiel F M Wouters
Journal:  Proc Am Thorac Soc       Date:  2005

Review 4.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

5.  Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins.

Authors:  G Engström; P Lind; B Hedblad; P Wollmer; L Stavenow; L Janzon; F Lindgärde
Journal:  Circulation       Date:  2002-11-12       Impact factor: 29.690

6.  Are patients with COPD psychologically distressed?

Authors:  E J Wagena; W A Arrindell; E F M Wouters; C P van Schayck
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

7.  Inflammatory response and body composition in chronic obstructive pulmonary disease.

Authors:  A A Eid; A A Ionescu; L S Nixon; V Lewis-Jenkins; S B Matthews; T L Griffiths; D J Shale
Journal:  Am J Respir Crit Care Med       Date:  2001-10-15       Impact factor: 21.405

8.  Risk of depression in patients with chronic obstructive pulmonary disease and its determinants.

Authors:  J G van Manen; P J E Bindels; F W Dekker; C J IJzermans; J S van der Zee; E Schadé
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

Review 9.  Systemic effects of chronic obstructive pulmonary disease.

Authors:  A G N Agustí; A Noguera; J Sauleda; E Sala; J Pons; X Busquets
Journal:  Eur Respir J       Date:  2003-02       Impact factor: 16.671

10.  Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study.

Authors:  D J Hole; G C Watt; G Davey-Smith; C L Hart; C R Gillis; V M Hawthorne
Journal:  BMJ       Date:  1996-09-21
View more
  1 in total

Review 1.  Multidisciplinary care of the patient with chronic obstructive pulmonary disease.

Authors:  Anne Marie Kuzma; Yvonne Meli; Catherine Meldrum; Patricia Jellen; Marianne Butler-Lebair; Debra Koczen-Doyle; Peter Rising; Kim Stavrolakes; Frances Brogan
Journal:  Proc Am Thorac Soc       Date:  2008-05-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.